
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5709987
[patent_doc_number] => 20060051332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Generation of histocompatible tissues using nuclear transplantation'
[patent_app_type] => utility
[patent_app_number] => 10/515705
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10737
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051332.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515705 | Generation of histocompatible tissues using nuclear transplantation | May 22, 2003 | Abandoned |
Array
(
[id] => 7403420
[patent_doc_number] => 20040023881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections'
[patent_app_type] => new
[patent_app_number] => 10/439047
[patent_app_country] => US
[patent_app_date] => 2003-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8609
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023881.pdf
[firstpage_image] =>[orig_patent_app_number] => 10439047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/439047 | Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections | May 15, 2003 | Abandoned |
Array
(
[id] => 7178865
[patent_doc_number] => 20050204407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family'
[patent_app_type] => utility
[patent_app_number] => 10/514316
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19707
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20050204407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514316
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514316 | Methods for identifying and developing compounds that interact with voltage-gated potassium channels of the kv4 family | May 13, 2003 | Abandoned |
Array
(
[id] => 5732249
[patent_doc_number] => 20060257366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Chimeric glycoproteins and pseudotyped lentiviral vectors'
[patent_app_type] => utility
[patent_app_number] => 10/512474
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 34825
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512474 | Chimeric glycoproteins and pseudotyped lentiviral vectors | Apr 24, 2003 | Issued |
Array
(
[id] => 6966560
[patent_doc_number] => 20050233457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Recombining viral vectors for the tetracycline-regulated expression of genes'
[patent_app_type] => utility
[patent_app_number] => 10/511237
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233457.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511237
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511237 | Recombining viral vectors for the tetracycline-regulated expression of genes | Apr 7, 2003 | Abandoned |
Array
(
[id] => 7355074
[patent_doc_number] => 20040048821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene'
[patent_app_type] => new
[patent_app_number] => 10/401116
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9473
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10401116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/401116 | Enhancement of drug cytotoxicity in tumor cells containing mutant Rb gene | Mar 25, 2003 | Abandoned |
Array
(
[id] => 6771432
[patent_doc_number] => 20030217372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Methods of using alpha 1b-adrenergic receptors'
[patent_app_type] => new
[patent_app_number] => 10/396952
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16071
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20030217372.pdf
[firstpage_image] =>[orig_patent_app_number] => 10396952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/396952 | Methods of using alpha 1b-adrenergic receptors | Mar 24, 2003 | Abandoned |
Array
(
[id] => 7136298
[patent_doc_number] => 20040044006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Methods of use of quinolone compounds against pneumococcal and haemophilus bacteria'
[patent_app_type] => new
[patent_app_number] => 10/395461
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14443
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044006.pdf
[firstpage_image] =>[orig_patent_app_number] => 10395461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/395461 | Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria | Mar 23, 2003 | Issued |
Array
(
[id] => 7233124
[patent_doc_number] => 20050256067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Method of preparing a treatment product, treatment product and a plasmid construct'
[patent_app_type] => utility
[patent_app_number] => 10/505933
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7266
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505933
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505933 | Method of preparing a treatment product, treatment product and a plasmid construct | Feb 26, 2003 | Abandoned |
Array
(
[id] => 53726
[patent_doc_number] => 07772459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Transgenic production in saliva'
[patent_app_type] => utility
[patent_app_number] => 10/505191
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34543
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505191 | Transgenic production in saliva | Feb 19, 2003 | Issued |
Array
(
[id] => 6796782
[patent_doc_number] => 20030175656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Hydrogel incorporated with bone growth promoting agents for dental and oral surgery'
[patent_app_type] => new
[patent_app_number] => 10/344942
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9882
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344942 | Hydrogel incorporated with bone growth promoting agents for dental and oral surgery | Feb 18, 2003 | Abandoned |
Array
(
[id] => 5726814
[patent_doc_number] => 20060057574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Tissue specific expression'
[patent_app_type] => utility
[patent_app_number] => 10/504809
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8482
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20060057574.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504809
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504809 | Tissue specific expression | Feb 18, 2003 | Abandoned |
Array
(
[id] => 6648686
[patent_doc_number] => 20030213003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Transgenically produced non-secreted proteins'
[patent_app_type] => new
[patent_app_number] => 10/358037
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11093
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20030213003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10358037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/358037 | Transgenically produced non-secreted proteins | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6769877
[patent_doc_number] => 20030215817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Modulation of gene expression in formation of fatty atherosclerotic lesions'
[patent_app_type] => new
[patent_app_number] => 10/182230
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 47289
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10182230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/182230 | Modulation of gene expression in formation of fatty atherosclerotic lesions | Feb 2, 2003 | Abandoned |
Array
(
[id] => 7467842
[patent_doc_number] => 20040053871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Immunization of infants'
[patent_app_type] => new
[patent_app_number] => 10/351630
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14370
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053871.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351630 | Immunization of infants | Jan 23, 2003 | Abandoned |
Array
(
[id] => 7280374
[patent_doc_number] => 20040062751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Methods for inhibiting angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/346589
[patent_app_country] => US
[patent_app_date] => 2003-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4934
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20040062751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10346589
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/346589 | Methods for inhibiting angiogenesis | Jan 16, 2003 | Abandoned |
Array
(
[id] => 83305
[patent_doc_number] => 07741112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Vector mediated organelle transfection'
[patent_app_type] => utility
[patent_app_number] => 10/498328
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11196
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498328
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498328 | Vector mediated organelle transfection | Dec 11, 2002 | Issued |
Array
(
[id] => 6952206
[patent_doc_number] => 20050227300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/497333
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3557
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10497333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/497333 | Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors | Dec 5, 2002 | Abandoned |
Array
(
[id] => 6661228
[patent_doc_number] => 20030135872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Gene targeting methods and vectors'
[patent_app_type] => new
[patent_app_number] => 10/309757
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13347
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135872.pdf
[firstpage_image] =>[orig_patent_app_number] => 10309757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/309757 | Gene targeting methods and vectors | Dec 2, 2002 | Abandoned |
Array
(
[id] => 7010244
[patent_doc_number] => 20050063960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Dna construct for assessing thymic function activity and therapeutical uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/496916
[patent_app_country] => US
[patent_app_date] => 2002-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4720
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20050063960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496916
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496916 | Dna construct for assessing thymic function activity and therapeutical uses thereof | Nov 28, 2002 | Abandoned |